In this upcoming one-hour webinar, PRECISONadvisors Vice President Richard Macaulay will moderate a lively discussion with our panel of European payer experts as they examine the next generation of gene therapies, and weigh considerations for policy makers as well as manufacturers.
Issues to be discussed by the panel will include:
-Gene therapy treatments for diseases that take years to develop (e.g. Huntington’s Disease, Prion diseases)
-Gene Therapies to prevent development of diseases in genetically susceptible individuals (e.g. early-onset familial Alzheimer’s disease)
-Gene therapies to be used in utero (with the potential to treat lethal and morbid perinatal diseases before birth, as well as potentially using existing gene therapies much earlier in disease progression).
The discussion will conclude with a live Q&A.